Titre : Vaginose bactérienne

Vaginose bactérienne : Questions médicales fréquentes

Termes MeSH sélectionnés :

Contraception
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vaginose bactérienne : Questions médicales les plus fréquentes", "headline": "Vaginose bactérienne : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vaginose bactérienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-21", "dateModified": "2025-02-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vaginose bactérienne" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vaginite", "url": "https://questionsmedicales.fr/mesh/D014627", "about": { "@type": "MedicalCondition", "name": "Vaginite", "code": { "@type": "MedicalCode", "code": "D014627", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C12.100.250.894.906" } } }, "about": { "@type": "MedicalCondition", "name": "Vaginose bactérienne", "alternateName": "Vaginosis, Bacterial", "code": { "@type": "MedicalCode", "code": "D016585", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christina A Muzny", "url": "https://questionsmedicales.fr/author/Christina%20A%20Muzny", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA." } }, { "@type": "Person", "name": "Jack D Sobel", "url": "https://questionsmedicales.fr/author/Jack%20D%20Sobel", "affiliation": { "@type": "Organization", "name": "Division of Infectious DiseasesWayne State University School of Medicine, Detroit, Michigan, USA jsobel@med.wayne.edu rakins@med.wayne.edu." } }, { "@type": "Person", "name": "Jane R Schwebke", "url": "https://questionsmedicales.fr/author/Jane%20R%20Schwebke", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, University of Alabama at Birmingham; Birmingham, AL, USA." } }, { "@type": "Person", "name": "Nuno Cerca", "url": "https://questionsmedicales.fr/author/Nuno%20Cerca", "affiliation": { "@type": "Organization", "name": "Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), Centre of Biological Engineering (CEB), University of Minho, Campus de Gualtar, Braga, 4710-057, Portugal." } }, { "@type": "Person", "name": "David N Fredricks", "url": "https://questionsmedicales.fr/author/David%20N%20Fredricks", "affiliation": { "@type": "Organization", "name": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The effect of contraceptive access reform on privately insured patients: Evidence from Delaware Contraceptive Access Now.", "datePublished": "2023-01-23", "url": "https://questionsmedicales.fr/article/36689399", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0280588" } }, { "@type": "ScholarlyArticle", "name": "Contraceptive method denial as downward contraceptive coercion: A mixed-methods mystery client study in Western Kenya.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35779578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.contraception.2022.06.014" } }, { "@type": "ScholarlyArticle", "name": "[Contraception in adolescents with obesity and diabetes mellitus].", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/36689719", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14341/probl12760" } }, { "@type": "ScholarlyArticle", "name": "The association between quality of contraceptive counseling and selection of contraceptive method post-counseling among women in Ethiopia.", "datePublished": "2023-05-11", "url": "https://questionsmedicales.fr/article/37178813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.contraception.2023.110060" } }, { "@type": "ScholarlyArticle", "name": "Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37535965", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/AOG.0000000000005277" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies urogénitales", "item": "https://questionsmedicales.fr/mesh/D000091642" }, { "@type": "ListItem", "position": 3, "name": "Maladies génitales", "item": "https://questionsmedicales.fr/mesh/D000091662" }, { "@type": "ListItem", "position": 4, "name": "Maladies de l'appareil génital féminin", "item": "https://questionsmedicales.fr/mesh/D005831" }, { "@type": "ListItem", "position": 5, "name": "Maladies du vagin", "item": "https://questionsmedicales.fr/mesh/D014623" }, { "@type": "ListItem", "position": 6, "name": "Vaginite", "item": "https://questionsmedicales.fr/mesh/D014627" }, { "@type": "ListItem", "position": 7, "name": "Vaginose bactérienne", "item": "https://questionsmedicales.fr/mesh/D016585" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vaginose bactérienne - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vaginose bactérienne", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vaginose bactérienne", "description": "Comment diagnostique-t-on la vaginose bactérienne ?\nQuels tests sont utilisés pour confirmer la vaginose ?\nLes symptômes sont-ils suffisants pour le diagnostic ?\nPeut-on confondre la vaginose avec d'autres infections ?\nQuel rôle joue le pH vaginal dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vaginose bactérienne", "description": "Quels sont les symptômes courants de la vaginose ?\nLa vaginose peut-elle être asymptomatique ?\nComment décrire l'odeur associée à la vaginose ?\nLes pertes vaginales sont-elles toujours présentes ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vaginose bactérienne", "description": "Comment prévenir la vaginose bactérienne ?\nLes rapports sexuels affectent-ils le risque de vaginose ?\nLes probiotiques peuvent-ils aider à prévenir la vaginose ?\nLe tabagisme influence-t-il le risque de vaginose ?\nLes vêtements peuvent-ils affecter la santé vaginale ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vaginose bactérienne", "description": "Quels traitements sont disponibles pour la vaginose ?\nLes traitements sont-ils efficaces à 100 % ?\nPeut-on traiter la vaginose avec des remèdes naturels ?\nFaut-il traiter la vaginose si elle est asymptomatique ?\nLes partenaires doivent-ils être traités ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vaginose bactérienne", "description": "Quelles complications peuvent survenir avec la vaginose ?\nLa vaginose peut-elle affecter la fertilité ?\nY a-t-il un lien entre vaginose et grossesse ?\nLes infections urinaires sont-elles liées à la vaginose ?\nLa vaginose peut-elle causer des douleurs pelviennes ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vaginose bactérienne", "description": "Quels sont les principaux facteurs de risque de vaginose ?\nL'utilisation de contraceptifs affecte-t-elle le risque ?\nLes antécédents d'infections vaginales augmentent-ils le risque ?\nLe stress peut-il influencer la vaginose ?\nLes changements alimentaires jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D016585?mesh_terms=Contraception&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la vaginose bactérienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des tests de pH vaginal et de sécrétions." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer la vaginose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'examen microscopique et le test de l'amine peuvent être utilisés." } }, { "@type": "Question", "name": "Les symptômes sont-ils suffisants pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes doivent être corroborés par des tests de laboratoire pour un diagnostic précis." } }, { "@type": "Question", "name": "Peut-on confondre la vaginose avec d'autres infections ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec des infections comme la candidose ou les IST." } }, { "@type": "Question", "name": "Quel rôle joue le pH vaginal dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un pH vaginal supérieur à 4,5 est souvent un indicateur de vaginose bactérienne." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la vaginose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des pertes vaginales anormales, une odeur forte et des démangeaisons." } }, { "@type": "Question", "name": "La vaginose peut-elle être asymptomatique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines femmes peuvent ne présenter aucun symptôme malgré la présence de l'infection." } }, { "@type": "Question", "name": "Comment décrire l'odeur associée à la vaginose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'odeur est souvent décrite comme un parfum de poisson, surtout après les rapports sexuels." } }, { "@type": "Question", "name": "Les pertes vaginales sont-elles toujours présentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certaines femmes peuvent avoir des pertes minimes ou absentes malgré l'infection." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les femmes." } }, { "@type": "Question", "name": "Comment prévenir la vaginose bactérienne ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène vaginale et éviter les douches vaginales peut aider à prévenir." } }, { "@type": "Question", "name": "Les rapports sexuels affectent-ils le risque de vaginose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir de nouveaux partenaires sexuels ou des rapports non protégés peut augmenter le risque." } }, { "@type": "Question", "name": "Les probiotiques peuvent-ils aider à prévenir la vaginose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que les probiotiques peuvent aider à rétablir l'équilibre vaginal." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque de vaginose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de vaginose bactérienne." } }, { "@type": "Question", "name": "Les vêtements peuvent-ils affecter la santé vaginale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter des vêtements serrés ou en matières synthétiques peut favoriser la vaginose." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la vaginose ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques comme le métronidazole ou la clindamycine sont couramment prescrits." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces à 100 % ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Bien que souvent efficaces, il existe un risque de récidive après le traitement." } }, { "@type": "Question", "name": "Peut-on traiter la vaginose avec des remèdes naturels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines femmes essaient des remèdes naturels, mais leur efficacité n'est pas prouvée scientifiquement." } }, { "@type": "Question", "name": "Faut-il traiter la vaginose si elle est asymptomatique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est recommandé même sans symptômes, surtout avant une intervention chirurgicale." } }, { "@type": "Question", "name": "Les partenaires doivent-ils être traités ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En général, le traitement des partenaires n'est pas nécessaire, sauf en cas de symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la vaginose ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent un risque accru d'infections sexuellement transmissibles et de complications pendant la grossesse." } }, { "@type": "Question", "name": "La vaginose peut-elle affecter la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Bien que rare, une vaginose non traitée peut contribuer à des problèmes de fertilité." } }, { "@type": "Question", "name": "Y a-t-il un lien entre vaginose et grossesse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaginose peut augmenter le risque de complications pendant la grossesse, comme l'accouchement prématuré." } }, { "@type": "Question", "name": "Les infections urinaires sont-elles liées à la vaginose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes atteintes de vaginose peuvent avoir un risque accru d'infections urinaires." } }, { "@type": "Question", "name": "La vaginose peut-elle causer des douleurs pelviennes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Bien que rare, certaines femmes peuvent ressentir des douleurs pelviennes en raison de la vaginose." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de vaginose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des changements hormonaux, des rapports sexuels fréquents et le tabagisme." } }, { "@type": "Question", "name": "L'utilisation de contraceptifs affecte-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains contraceptifs hormonaux peuvent influencer le déséquilibre bactérien vaginal." } }, { "@type": "Question", "name": "Les antécédents d'infections vaginales augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes ayant des antécédents d'infections vaginales sont plus susceptibles de développer une vaginose." } }, { "@type": "Question", "name": "Le stress peut-il influencer la vaginose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter le système immunitaire et augmenter le risque d'infections vaginales." } }, { "@type": "Question", "name": "Les changements alimentaires jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut affecter la flore vaginale et augmenter le risque de vaginose." } } ] } ] }

Sources (2176 au total)

The effect of contraceptive access reform on privately insured patients: Evidence from Delaware Contraceptive Access Now.

Many states are implementing comprehensive programs aimed at reducing persistent barriers to contraceptive care. Evidence on the effectiveness of these programs is essential for practice improvement a... To evaluate changes in the probability of initiating a contraceptive method by women with employer sponsored insurance after implementation of Delaware Contraceptive Access Now (DelCAN), a statewide i... We used a difference-in-differences design to examine contraceptive initiation rates. Data came from IBM Marketscan and covered women age 15-44 enrolled in employer sponsored insurance. The primary ou... The cohort of 4,550,459 enrollees generated a sample of 11,888,837 person-years and 615,670 childbirth hospitalizations. Difference-in-differences estimates suggested that DelCAN was associated with a... A comprehensive statewide program was associated with increased LARC insertion rates among enrollees with employer sponsored insurance. Understanding the effect of these programs is critical for on-go...

Contraceptive method denial as downward contraceptive coercion: A mixed-methods mystery client study in Western Kenya.

This study uses mixed methods to quantify the frequency of method denial in Western Kenya and describe how this barrier impacts contraceptive access.... We estimate the frequency of method denial using data from mystery clients deployed to 57 randomly selected public-sector facilities located in Western Kenya. These quantitative data are triangulated ... In 21% of mystery client visits, the client was denied their preferred contraceptive method. In 13% of visits, mystery clients were unable to procure any method. Method denial was primarily motivated ... Method denial disrupts contraceptive access among women who have already overcome financial and logistical barriers to arrive at a health care facility. Further attention to this barrier is required t... Providers may impose unnecessary restrictions on contraceptive access that limit the ability of women to achieve their desired family size. Unwarranted method denial occurs in approximately one out of...

The association between quality of contraceptive counseling and selection of contraceptive method post-counseling among women in Ethiopia.

To better understand the relationship between high-quality contraceptive counseling and met family planning needs, we examined the association between quality of counseling and selection of a method p... We used post-counseling survey data from women receiving care in public health centers and nongovernmental clinics in three regions in Ethiopia. Among women whose reason for visit was requesting a con... There was a nonsignificant increase in odds of selecting contraception with increasing total QCC scale scores (adjusted odds ratio [aOR] 2.35, 0.43-12.95). However, among women experiencing no disresp... Increasing QCC is associated with selecting contraception among women requesting contraception. Additionally, probing for negative experiences can reveal feelings of disrespect and abuse that could le... Our study assesses contraceptive counseling quality using a validated tool with items on provider pressure and other forms of disrespect and abuse; findings highlight the importance of respectful trea...

Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.

To describe patterns of contraceptive method switching and long-acting reversible contraception (LARC) removal in a large network of community health centers.... We conducted a retrospective cohort study using individual-level electronic health record data from 489 clinics in 20 states from 2016 to 2021. We used logistic regression models, including individual... Among 151,786 patients with 513,753 contraceptive encounters, 22.1% switched to another method at least once over the 4-year observation period, and switching patterns were varied. In patients with ba... Community health centers provide access to method switching and LARC removal. Contraceptive switching and LARC removal are common, and clinicians should normalize switching and LARC removal among pati...

Continuation rates of hormonal intrauterine devices in adolescents and young adults when placed for contraceptive and non-contraceptive indications.

This study aimed to estimate and compare continuation rates of hormonal intrauterine devices (IUDs) when placed for contraceptive or menstrual management indications in adolescents and young adults.... We conducted a secondary analysis of a prospectively collected database of all hormonal IUD insertions from January 1, 2017 through December 31, 2020, with at least 1-year follow-up, across four Adole... A total of 936 IUD insertions were attempted, 45% for contraception only, 18% for menstrual management only, and 37% for both indications. Insertion was successful in 868 (93%) attempts, and success d... IUD continuation rates were high among adolescents and young adults and did not significantly differ when placed for contraceptive or non-contraceptive indication in the first year of use.... Adolescents and young adults may seek the hormonal IUD for contraception and/or menstrual management. Our study found that IUD continuation rates were high at 1 year regardless of the indication for u...

Elevating the patient voice in contraceptive care quality improvement: A qualitative study of patient preferences for peripartum contraceptive care.

Patient-centeredness is an important indicator of peripartum contraceptive care quality. Prior work demonstrates how care fragmentation, provider biases, and other factors sometimes undermine the pati... For this qualitative study, we recruited a convenience sample of individuals receiving prenatal care at the study site and participating in an online survey about their experience of peripartum contra... Interviews (lasting 7-26 min) included 21 postpartum individuals, who were largely White with high levels of formal education. Many participants described suboptimal care experiences characterized by ... We newly identify four key domains of patient preferences for peripartum contraceptive care. Additional research is needed to understand peripartum contraceptive care preferences among diverse patient... Patients want peripartum contraceptive care to provide comprehensive, anticipatory information; elicit and respond to their counseling and decision-making preferences; and demonstrate respect for thei...

Contraception utilization in women with pregestational diabetes.

To compare contraception use between women with and without pregestational diabetes.... Cross-sectional data on women aged 18-44 years from 2011 to 2017 National Survey of Family Growth (NSFG) was analysed. Maternal diabetes was defined as the presence of pre-gestational type 1 or type 2... Among the total study sample of 28,454, 1344 (4.7%) had pregestational diabetes. Unadjusted analysis showed women with a history of pregestational diabetes were more likely to use permanent contracept... In this analysis, we found that women with pregestational diabetes were more likely to use permanent contraception methods compared to women without pregestational diabetes; however over a quarter of ...